Stablecoin Development Corp. Stablecoin Development Corp.

Stablecoin Development Corp.

SDEV

Rank in Stocks #23004
Stablecoin Development Corp. specializes in manufacturing and distributing eye... Stablecoin Development Corp. specializes in manufacturing and distributing eye and skin health solutions that have undergone rigorous scientific development and proven efficacy in clinical settings. Their product portfolio features prominent brands such as Avenova, NeutroPhase, and DERMAdoctor. This enterprise was established on January 19, 2000, and its main office is situated in Emeryville, California.
Share Price
$0.9068
Last synced: 2026-11-09
Market Cap
$46.93M
Change (1 day)
-7.47%
Change (1 year)
-
Country

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Trade Stablecoin Development Corp. (SDEV)

Category

Healthcare
P/B ratio for Stablecoin Development Corp. (SDEV)
P/B ratio as of November 2026 TTM: 1.17
According to Stablecoin Development Corp.'s latest financial reports and stock price, its current price-to-book ratio (TTM) is 1.17. At the end of 2025 the company had a P/B ratio of -0.32.
P/B ratio history for Stablecoin Development Corp. from 2025 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) 1.17 -466.63%
2025 -0.32 0.00%
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
4.3759 272.99%
US
3.754 219.98%
SE
2.7671 135.86%
FR
2.2619 92.80%
HK
5.0598 331.28%
IT

Questions about Stablecoin Development Corp.'s P/B ratio

What is Stablecoin Development Corp.'s P/B ratio?

Stablecoin Development Corp.'s P/B ratio is 1.17, as of Nov 2026.

How does Stablecoin Development Corp.'s P/B ratio compare with similar companies?

Stablecoin Development Corp.'s P/B ratio (1.17) is lower than that of all 5 similar companies listed above. The highest among them is Recordati Industria Chimica e Farmaceutica S.p.A., with 5.06.